AI assistant
Sending…
PLUS THERAPEUTICS, INC. — Director's Dealing 2015
Feb 3, 2015
34301_dirs_2015-02-03_cccc0dbf-498b-4a26-8468-1f10d8718820.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2015-01-30
Reporting Person: Girao Tiago (VP & Chief Financial Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-01-30 | Employee Stock Option | $0.48 | A | 120000 | Acquired | 2025-01-30 | Common Stock (120000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 60000 | Direct |
Footnotes
F1: The Employee Stock options vest 1/48th each month from date of grant, subject to remaining an employee of the Company.
More from PLUS THERAPEUTICS, INC.
Regulatory Filings
2026
Jun 18
Capital/Financing Update
2026
Jun 5
Regulatory Filings
2026
Jun 5
Capital/Financing Update
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 15
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Call Transcript
2026
May 14
Regulatory Filings
2026
Apr 21
Board/Management Information
2026
Apr 9